Free · 13,591 studies indexed

lighttherapyresearch.com is a free index of research on photobiomodulation and light therapy, gathered from the world’s journals and trial registries.

Sections
Oral & Dental

Impact of oral mucositis treated by photobiomodulation protocol on the quality of life of pediatric oncology patients with acute lymphoblastic leukemia

Greater mucositis severity and longer wound healing time were the main factors associated with worse outcomes.

Excerpt from the paper’s abstract. Read the full paper for the details.

AI-generated summary

The authors conducted a cross-sectional study of 113 pediatric patients with acute lymphoblastic leukemia receiving methotrexate chemotherapy, examining factors linked to oral mucositis and quality of life. They report that 85% of participants reported a high impact on quality of life, with greater mucositis severity and longer wound healing time associated with worse outcomes. The study cannot establish a causal effect of photobiomodulation, which was routinely applied.

Participants
113
Who or what was studied
Pediatric patients aged 5 to 18 years with acute lymphoblastic leukemia undergoing methotrexate-based chemotherapy at a university hospital in Northeastern Brazil
Limits stated in the abstract
The cross-sectional design and systematic, non-randomized photobiomodulation use preclude causal inference about its independent effect.

Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.

Abstract

To assess factors associated with methotrexate-induced oral mucositis and its impact on the quality of life of pediatric patients with acute lymphoblastic leukemia, considering chemotherapy dose and mucositis severity within a clinical context where photobiomodulation is routinely used as part of the institutional care protocol. A cross-sectional study was conducted with 113 pediatric patients aged 5 to 18 years undergoing methotrexate-based chemotherapy between 2020 and 2024 in a university hospital in Northeastern Brazil. Data were collected using the Children's International Mucositis Evaluation Scale (ChIMES; self-report and proxy), the Child Oral Impacts on Daily Performances (C-OIDP), the WHO Oral Mucositis Grading Scale, photobiomodulation records, and chemotherapy regimen data. Descriptive statistics, Spearman correlation, and multiple linear regression analyses were performed (α = 0.05). Among the participants, 85% reported a high impact on quality of life. The mean age was 10.8 years (SD = 3.49), and most participants were boys. Higher mucositis severity, older age, higher methotrexate doses, and longer wound healing time were associated with worse quality of life. A strong positive correlation was observed between C-OIDP and ChIMES scores (p < 0.001). In the regression analysis, mucositis severity (β = 0.304; p = 0.021) and wound healing time (β = 0.492; p < 0.001) remained significantly associated with higher impact scores. Methotrexate-induced oral mucositis was associated with a substantial negative impact on quality of life in pediatric patients with acute lymphoblastic leukemia. Greater mucositis severity and longer wound healing time were the main factors associated with worse outcomes. Although photobiomodulation was systematically applied as a preventive and therapeutic intervention, no causal inference regarding its independent effect can be established.

Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.

How to read a single study: what to check before relying on this kind of research.

Terms in this paper: Photobiomodulation, Oral mucositis, Wound healing, Dose. Each links to its definition in the glossary.

A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.

Related studies